$ News

Here’s Why NeuroMetrix, Inc. (NASDAQ:NURO) Is Among the Best Diabetes Stocks to Buy Under $10

NeuroMetrix Q3 Loss Narrows Y/Y, Quell Sales Drives Growth

NeuroMetrix Third Quarter 2024 Earnings: US$0.75 loss per share (vs US$1.66 loss in 3Q 2023)

NeuroMetrix Reports Q3 2024 Business Highlights

NeuroMetrix Reiterates its Review of Strategic Alternatives

NeuroMetrix says opportunities reviewed not in best interest at this time

NeuroMetrix, Inc. (NURO) Q2 2024 Earnings Call Transcript

NeuroMetrix Second Quarter 2024 Earnings: US$0.75 loss per share (vs US$1.56 loss in 2Q 2023)

NeuroMetrix Reports Q2 2024 Business Highlights and Update on Review of Strategic Options

NURO Stock Earnings: NeuroMetrix Reported Results for Q2 2024

NeuroMetrix GAAP EPS of -$0.74, revenue of $0.8M

NeuroMetrix reports Q2 EPS (74c) vs. ($1.56) last year

NeuroMetrix implements wind down of ADVANCE business

NeuroMetrix reports Q2 revenue $769,148 vs. $1.66M last year

NeuroMetrix provides update on review of strategic options

NeuroMetrix, Inc. Announces Date for Second Quarter 2024 Business Highlights Conference Call